Danforth Advisors Acquires Elite BioPharma Consulting
September 6, 2023
Danforth Advisors has acquired Elite BioPharma Consulting to expand its Development Strategy & Operations (DS&O) practice, adding clinical development operations, project and trial management, clinical monitoring, program management, regulatory affairs, and medical writing capabilities. The founders of Elite will continue to lead the team as Danforth integrates Elite's expertise into its variable resource model for life science companies.
- Buyers
- Danforth Advisors, LLC
- Targets
- Elite BioPharma Consulting, Inc.
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Danforth Advisors Acquires PharmaDirections
August 25, 2025
Healthcare Services
Danforth Advisors, a PE-backed life sciences advisory platform, has acquired PharmaDirections, a virtual drug development partner. The acquisition adds more than 150 specialists and expands Danforth's integrated capabilities across discovery, non-clinical and clinical development, CMC, regulatory strategy, and program and alliance management.
-
Danforth Advisors Acquires VPMR
December 17, 2024
Healthcare Services
Danforth Advisors, a life-science strategic and operational advisory firm, acquired VPMR, a full-service global market research firm serving life science and healthcare clients. The acquisition expands Danforth’s commercial readiness and market research capabilities; Allison Fuller will remain President of VPMR.
-
Danforth Advisors Acquires Advyzom
September 10, 2024
Healthcare Services
Danforth Advisors has acquired Advyzom, a New Jersey–based regulatory affairs consultancy of approximately 30 specialists, expanding Danforth's clinical and regulatory capabilities to offer a comprehensive suite of services for life science companies. The acquisition integrates Advyzom's regulatory strategy, FDA liaison, medical writing, and submissions expertise into Danforth's platform to better support clients across development, approval, and market entry.
-
Danforth Advisors Acquires BW Health Group
May 29, 2024
Healthcare Services
Danforth Advisors has acquired BW Health Group, a commercialization and product-launch services platform serving small- and mid-sized life science companies. The deal adds commercial readiness, launch planning and biopharma marketing capabilities (Benchworks and BW Consulting) to Danforth's integrated life-science advisory and operational services offering.
-
Danforth Advisors Acquires Argot Partners
January 4, 2023
Marketing & Advertising
Danforth Advisors, a provider of outsourced corporate and clinical business functions for the life sciences, has acquired Argot Partners, a strategic communications and investor-relations consultancy focused on life sciences. The acquisition expands Danforth's integrated service offering to include strategic communications; Argot's founders will continue to lead the firm.
-
Avesi Partners Invests in Danforth Advisors
December 16, 2021
Healthcare Services
Avesi Partners has made a private equity investment in Danforth Advisors, with Stone‑Goff Partners exiting its stake. Danforth, headquartered in Waltham, Massachusetts, provides financial, operational and clinical business support to life science companies; the investment is intended to help scale the company's services, people and geographic footprint to meet growing demand in the life sciences market.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.